<DOC>
	<DOCNO>NCT02552732</DOCNO>
	<brief_summary>The aim feasibility study provide data subsequent randomize controlled trial investigate patient outcomes improved acute COPD exacerbation use domiciliary nasal high flow therapy ( NHF ) compare standard care . This feasibility study investigate follow : process , resource , management scientific aspect deliver NHF adjunct therapy COPD patient .</brief_summary>
	<brief_title>Nasal High Flow Therapy 30 Day Readmission Study</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>18 year age old Male female Admitted respiratory ward ( ) either recruit hospital AECOPD primary diagnostic reason admission . Given new home oxygen therapy prescription current hospital admission The investigator believe participant care giver unable safely use myAIRVO 2 device follow discharge They condition , investigator 's discretion , believe may present safety risk impact feasibility study study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>